Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions

In February 2018, the Melanoma Research Foundation and the Moffitt Cancer Center hosted the Second Summit on Melanoma Central Nervous System Metastases in Tampa, Florida. The meeting included investigators from multiple academic centers and disciplines. A consensus summary of the progress and challe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pigment cell and melanoma research 2020-07, Vol.33 (4), p.527-541
Hauptverfasser: Glitza, Isabella C., Smalley, Keiran S. M., Brastianos, Priscilla K., Davies, Michael A., McCutcheon, Ian, Liu, James K. C., Ahmed, Kamran A., Arrington, John A., Evernden, Brittany R., Smalley, Inna, Eroglu, Zeynep, Khushalani, Nikhil, Margolin, Kim, Kluger, Harriet, Atkins, Michael B., Tawbi, Hussein, Boire, Adrienne, Forsyth, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 541
container_issue 4
container_start_page 527
container_title Pigment cell and melanoma research
container_volume 33
creator Glitza, Isabella C.
Smalley, Keiran S. M.
Brastianos, Priscilla K.
Davies, Michael A.
McCutcheon, Ian
Liu, James K. C.
Ahmed, Kamran A.
Arrington, John A.
Evernden, Brittany R.
Smalley, Inna
Eroglu, Zeynep
Khushalani, Nikhil
Margolin, Kim
Kluger, Harriet
Atkins, Michael B.
Tawbi, Hussein
Boire, Adrienne
Forsyth, Peter
description In February 2018, the Melanoma Research Foundation and the Moffitt Cancer Center hosted the Second Summit on Melanoma Central Nervous System Metastases in Tampa, Florida. The meeting included investigators from multiple academic centers and disciplines. A consensus summary of the progress and challenges in melanoma parenchymal brain metastases was published (Eroglu et al., Pigment Cell & Melanoma Research, 2019, 32, 458). Here, we will describe the current state of basic, translational, clinical research, and therapeutic management, for melanoma patients with leptomeningeal disease. We also outline key challenges and barriers to be overcome to make progress in this deadly disease.
doi_str_mv 10.1111/pcmr.12861
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10126834</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2408472924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4491-498125c220d21b52e019615c559f514a94a0709ec2b7e0662de49a3041a8bdc53</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhkNR2lp70x8gAW9EujUnk8xMelPK4hesKKLQu5DNnGlTZpJpklH67826dalemJsE8uThzXkJOQF2BmW9mewYz4C3NeyRQ2ikXIBor57szg0ckGcp3TJWM6mqfXJQgYJaMHZI-hVOOYzonb9GM9DOJTQJqfN0xMH4MBo6mezQ53ROLz2dp85kpDnQHNHk8jKfUntjhgGLIZ1S4zvaz3mOWGQRbXbBp-fkaW-GhMcP-xH5_u7tt-WHxerz-4_Ly9XCCqFgIVQLXFrOWcdhLTkyUDVIK6XqJQijhGENU2j5ukFW17xDoUzFBJh23VlZHZGLrXea1yN2tqSLZtBTdKOJ9zoYp_--8e5GX4cfGhjwuq1EMbx6MMRwN2PKenTJ4lBmgWFOmleV3MyVNQV9-Q96G-boy_80F6wVDVd8I3y9pWwMKUXsd2mA6U1_etOf_t1fgV88zr9D_xRWANgCP92A9_9R6S_LT1-30l_nS6YQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2408472924</pqid></control><display><type>article</type><title>Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Glitza, Isabella C. ; Smalley, Keiran S. M. ; Brastianos, Priscilla K. ; Davies, Michael A. ; McCutcheon, Ian ; Liu, James K. C. ; Ahmed, Kamran A. ; Arrington, John A. ; Evernden, Brittany R. ; Smalley, Inna ; Eroglu, Zeynep ; Khushalani, Nikhil ; Margolin, Kim ; Kluger, Harriet ; Atkins, Michael B. ; Tawbi, Hussein ; Boire, Adrienne ; Forsyth, Peter</creator><creatorcontrib>Glitza, Isabella C. ; Smalley, Keiran S. M. ; Brastianos, Priscilla K. ; Davies, Michael A. ; McCutcheon, Ian ; Liu, James K. C. ; Ahmed, Kamran A. ; Arrington, John A. ; Evernden, Brittany R. ; Smalley, Inna ; Eroglu, Zeynep ; Khushalani, Nikhil ; Margolin, Kim ; Kluger, Harriet ; Atkins, Michael B. ; Tawbi, Hussein ; Boire, Adrienne ; Forsyth, Peter</creatorcontrib><description>In February 2018, the Melanoma Research Foundation and the Moffitt Cancer Center hosted the Second Summit on Melanoma Central Nervous System Metastases in Tampa, Florida. The meeting included investigators from multiple academic centers and disciplines. A consensus summary of the progress and challenges in melanoma parenchymal brain metastases was published (Eroglu et al., Pigment Cell &amp; Melanoma Research, 2019, 32, 458). Here, we will describe the current state of basic, translational, clinical research, and therapeutic management, for melanoma patients with leptomeningeal disease. We also outline key challenges and barriers to be overcome to make progress in this deadly disease.</description><identifier>ISSN: 1755-1471</identifier><identifier>ISSN: 1755-148X</identifier><identifier>EISSN: 1755-148X</identifier><identifier>DOI: 10.1111/pcmr.12861</identifier><identifier>PMID: 31916400</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Brain cancer ; Cell-Free Nucleic Acids - metabolism ; Central nervous system ; Clinical Trials as Topic ; Humans ; intrathecal therapy ; leptomeningeal carcinomatosis ; leptomeningeal disease ; Melanoma ; Melanoma - complications ; Meningeal Neoplasms - complications ; Meningeal Neoplasms - diagnosis ; Meningeal Neoplasms - epidemiology ; Meningeal Neoplasms - therapy ; Meninges ; Metastases ; Metastasis ; Molecular Targeted Therapy ; Neoplastic Cells, Circulating - pathology ; neoplastic meningitis ; Patients</subject><ispartof>Pigment cell and melanoma research, 2020-07, Vol.33 (4), p.527-541</ispartof><rights>2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2020 John Wiley &amp; Sons A/S</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4491-498125c220d21b52e019615c559f514a94a0709ec2b7e0662de49a3041a8bdc53</citedby><cites>FETCH-LOGICAL-c4491-498125c220d21b52e019615c559f514a94a0709ec2b7e0662de49a3041a8bdc53</cites><orcidid>0000-0003-1089-9307 ; 0000-0002-3756-8594 ; 0000-0002-2307-7030 ; 0000-0002-0977-0912 ; 0000-0002-4530-7765</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpcmr.12861$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpcmr.12861$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31916400$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glitza, Isabella C.</creatorcontrib><creatorcontrib>Smalley, Keiran S. M.</creatorcontrib><creatorcontrib>Brastianos, Priscilla K.</creatorcontrib><creatorcontrib>Davies, Michael A.</creatorcontrib><creatorcontrib>McCutcheon, Ian</creatorcontrib><creatorcontrib>Liu, James K. C.</creatorcontrib><creatorcontrib>Ahmed, Kamran A.</creatorcontrib><creatorcontrib>Arrington, John A.</creatorcontrib><creatorcontrib>Evernden, Brittany R.</creatorcontrib><creatorcontrib>Smalley, Inna</creatorcontrib><creatorcontrib>Eroglu, Zeynep</creatorcontrib><creatorcontrib>Khushalani, Nikhil</creatorcontrib><creatorcontrib>Margolin, Kim</creatorcontrib><creatorcontrib>Kluger, Harriet</creatorcontrib><creatorcontrib>Atkins, Michael B.</creatorcontrib><creatorcontrib>Tawbi, Hussein</creatorcontrib><creatorcontrib>Boire, Adrienne</creatorcontrib><creatorcontrib>Forsyth, Peter</creatorcontrib><title>Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions</title><title>Pigment cell and melanoma research</title><addtitle>Pigment Cell Melanoma Res</addtitle><description>In February 2018, the Melanoma Research Foundation and the Moffitt Cancer Center hosted the Second Summit on Melanoma Central Nervous System Metastases in Tampa, Florida. The meeting included investigators from multiple academic centers and disciplines. A consensus summary of the progress and challenges in melanoma parenchymal brain metastases was published (Eroglu et al., Pigment Cell &amp; Melanoma Research, 2019, 32, 458). Here, we will describe the current state of basic, translational, clinical research, and therapeutic management, for melanoma patients with leptomeningeal disease. We also outline key challenges and barriers to be overcome to make progress in this deadly disease.</description><subject>Brain cancer</subject><subject>Cell-Free Nucleic Acids - metabolism</subject><subject>Central nervous system</subject><subject>Clinical Trials as Topic</subject><subject>Humans</subject><subject>intrathecal therapy</subject><subject>leptomeningeal carcinomatosis</subject><subject>leptomeningeal disease</subject><subject>Melanoma</subject><subject>Melanoma - complications</subject><subject>Meningeal Neoplasms - complications</subject><subject>Meningeal Neoplasms - diagnosis</subject><subject>Meningeal Neoplasms - epidemiology</subject><subject>Meningeal Neoplasms - therapy</subject><subject>Meninges</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Molecular Targeted Therapy</subject><subject>Neoplastic Cells, Circulating - pathology</subject><subject>neoplastic meningitis</subject><subject>Patients</subject><issn>1755-1471</issn><issn>1755-148X</issn><issn>1755-148X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV1rFDEUhkNR2lp70x8gAW9EujUnk8xMelPK4hesKKLQu5DNnGlTZpJpklH67826dalemJsE8uThzXkJOQF2BmW9mewYz4C3NeyRQ2ikXIBor57szg0ckGcp3TJWM6mqfXJQgYJaMHZI-hVOOYzonb9GM9DOJTQJqfN0xMH4MBo6mezQ53ROLz2dp85kpDnQHNHk8jKfUntjhgGLIZ1S4zvaz3mOWGQRbXbBp-fkaW-GhMcP-xH5_u7tt-WHxerz-4_Ly9XCCqFgIVQLXFrOWcdhLTkyUDVIK6XqJQijhGENU2j5ukFW17xDoUzFBJh23VlZHZGLrXea1yN2tqSLZtBTdKOJ9zoYp_--8e5GX4cfGhjwuq1EMbx6MMRwN2PKenTJ4lBmgWFOmleV3MyVNQV9-Q96G-boy_80F6wVDVd8I3y9pWwMKUXsd2mA6U1_etOf_t1fgV88zr9D_xRWANgCP92A9_9R6S_LT1-30l_nS6YQ</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Glitza, Isabella C.</creator><creator>Smalley, Keiran S. M.</creator><creator>Brastianos, Priscilla K.</creator><creator>Davies, Michael A.</creator><creator>McCutcheon, Ian</creator><creator>Liu, James K. C.</creator><creator>Ahmed, Kamran A.</creator><creator>Arrington, John A.</creator><creator>Evernden, Brittany R.</creator><creator>Smalley, Inna</creator><creator>Eroglu, Zeynep</creator><creator>Khushalani, Nikhil</creator><creator>Margolin, Kim</creator><creator>Kluger, Harriet</creator><creator>Atkins, Michael B.</creator><creator>Tawbi, Hussein</creator><creator>Boire, Adrienne</creator><creator>Forsyth, Peter</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1089-9307</orcidid><orcidid>https://orcid.org/0000-0002-3756-8594</orcidid><orcidid>https://orcid.org/0000-0002-2307-7030</orcidid><orcidid>https://orcid.org/0000-0002-0977-0912</orcidid><orcidid>https://orcid.org/0000-0002-4530-7765</orcidid></search><sort><creationdate>202007</creationdate><title>Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions</title><author>Glitza, Isabella C. ; Smalley, Keiran S. M. ; Brastianos, Priscilla K. ; Davies, Michael A. ; McCutcheon, Ian ; Liu, James K. C. ; Ahmed, Kamran A. ; Arrington, John A. ; Evernden, Brittany R. ; Smalley, Inna ; Eroglu, Zeynep ; Khushalani, Nikhil ; Margolin, Kim ; Kluger, Harriet ; Atkins, Michael B. ; Tawbi, Hussein ; Boire, Adrienne ; Forsyth, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4491-498125c220d21b52e019615c559f514a94a0709ec2b7e0662de49a3041a8bdc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Brain cancer</topic><topic>Cell-Free Nucleic Acids - metabolism</topic><topic>Central nervous system</topic><topic>Clinical Trials as Topic</topic><topic>Humans</topic><topic>intrathecal therapy</topic><topic>leptomeningeal carcinomatosis</topic><topic>leptomeningeal disease</topic><topic>Melanoma</topic><topic>Melanoma - complications</topic><topic>Meningeal Neoplasms - complications</topic><topic>Meningeal Neoplasms - diagnosis</topic><topic>Meningeal Neoplasms - epidemiology</topic><topic>Meningeal Neoplasms - therapy</topic><topic>Meninges</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Molecular Targeted Therapy</topic><topic>Neoplastic Cells, Circulating - pathology</topic><topic>neoplastic meningitis</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glitza, Isabella C.</creatorcontrib><creatorcontrib>Smalley, Keiran S. M.</creatorcontrib><creatorcontrib>Brastianos, Priscilla K.</creatorcontrib><creatorcontrib>Davies, Michael A.</creatorcontrib><creatorcontrib>McCutcheon, Ian</creatorcontrib><creatorcontrib>Liu, James K. C.</creatorcontrib><creatorcontrib>Ahmed, Kamran A.</creatorcontrib><creatorcontrib>Arrington, John A.</creatorcontrib><creatorcontrib>Evernden, Brittany R.</creatorcontrib><creatorcontrib>Smalley, Inna</creatorcontrib><creatorcontrib>Eroglu, Zeynep</creatorcontrib><creatorcontrib>Khushalani, Nikhil</creatorcontrib><creatorcontrib>Margolin, Kim</creatorcontrib><creatorcontrib>Kluger, Harriet</creatorcontrib><creatorcontrib>Atkins, Michael B.</creatorcontrib><creatorcontrib>Tawbi, Hussein</creatorcontrib><creatorcontrib>Boire, Adrienne</creatorcontrib><creatorcontrib>Forsyth, Peter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pigment cell and melanoma research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glitza, Isabella C.</au><au>Smalley, Keiran S. M.</au><au>Brastianos, Priscilla K.</au><au>Davies, Michael A.</au><au>McCutcheon, Ian</au><au>Liu, James K. C.</au><au>Ahmed, Kamran A.</au><au>Arrington, John A.</au><au>Evernden, Brittany R.</au><au>Smalley, Inna</au><au>Eroglu, Zeynep</au><au>Khushalani, Nikhil</au><au>Margolin, Kim</au><au>Kluger, Harriet</au><au>Atkins, Michael B.</au><au>Tawbi, Hussein</au><au>Boire, Adrienne</au><au>Forsyth, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions</atitle><jtitle>Pigment cell and melanoma research</jtitle><addtitle>Pigment Cell Melanoma Res</addtitle><date>2020-07</date><risdate>2020</risdate><volume>33</volume><issue>4</issue><spage>527</spage><epage>541</epage><pages>527-541</pages><issn>1755-1471</issn><issn>1755-148X</issn><eissn>1755-148X</eissn><abstract>In February 2018, the Melanoma Research Foundation and the Moffitt Cancer Center hosted the Second Summit on Melanoma Central Nervous System Metastases in Tampa, Florida. The meeting included investigators from multiple academic centers and disciplines. A consensus summary of the progress and challenges in melanoma parenchymal brain metastases was published (Eroglu et al., Pigment Cell &amp; Melanoma Research, 2019, 32, 458). Here, we will describe the current state of basic, translational, clinical research, and therapeutic management, for melanoma patients with leptomeningeal disease. We also outline key challenges and barriers to be overcome to make progress in this deadly disease.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31916400</pmid><doi>10.1111/pcmr.12861</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-1089-9307</orcidid><orcidid>https://orcid.org/0000-0002-3756-8594</orcidid><orcidid>https://orcid.org/0000-0002-2307-7030</orcidid><orcidid>https://orcid.org/0000-0002-0977-0912</orcidid><orcidid>https://orcid.org/0000-0002-4530-7765</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1755-1471
ispartof Pigment cell and melanoma research, 2020-07, Vol.33 (4), p.527-541
issn 1755-1471
1755-148X
1755-148X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10126834
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Brain cancer
Cell-Free Nucleic Acids - metabolism
Central nervous system
Clinical Trials as Topic
Humans
intrathecal therapy
leptomeningeal carcinomatosis
leptomeningeal disease
Melanoma
Melanoma - complications
Meningeal Neoplasms - complications
Meningeal Neoplasms - diagnosis
Meningeal Neoplasms - epidemiology
Meningeal Neoplasms - therapy
Meninges
Metastases
Metastasis
Molecular Targeted Therapy
Neoplastic Cells, Circulating - pathology
neoplastic meningitis
Patients
title Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T06%3A45%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leptomeningeal%20disease%20in%20melanoma%20patients:%20An%20update%20to%20treatment,%20challenges,%20and%20future%20directions&rft.jtitle=Pigment%20cell%20and%20melanoma%20research&rft.au=Glitza,%20Isabella%20C.&rft.date=2020-07&rft.volume=33&rft.issue=4&rft.spage=527&rft.epage=541&rft.pages=527-541&rft.issn=1755-1471&rft.eissn=1755-148X&rft_id=info:doi/10.1111/pcmr.12861&rft_dat=%3Cproquest_pubme%3E2408472924%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2408472924&rft_id=info:pmid/31916400&rfr_iscdi=true